These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8196160)

  • 21. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: role of pulmonary veins.
    Derejko P; Szumowski LJ; Sanders P; Krupa W; Bodalski R; Orczykowski M; Urbanek P; Zakrzewska J; Lim HS; Lau DH; Kuśnierz J; Walczak F
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):280-6. PubMed ID: 22035173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
    Duckeck W; Kuck KH
    Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation and atrial vulnerability in the Wolff-Parkinson-White syndrome.
    Asano Y; Kaneko K; Matsumoto K; Saito J; Yamamoto T; Dohi Y
    Jpn Circ J; 1991 Mar; 55(3):287-96. PubMed ID: 2030555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genesis of auricular fibrillation in the Wolff-Parkinson-White syndrome].
    Gressard A; Atallah G; Chatelain MT; Touboul P
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1277-82. PubMed ID: 6797365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial electrophysiological features in patients with Wolff-Parkinson-White and atrial fibrillation: absence of rate adaptation of intraatrial conduction time parameters.
    Riccardi R; Gaita F; Giustetto C; Gardiol S
    Pacing Clin Electrophysiol; 1997 May; 20(5 Pt 1):1318-27. PubMed ID: 9170133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome.
    Favale S; Minafra F; Massari V; Tritto M; Rizzon P
    Int J Cardiol; 1991 Feb; 30(2):209-14. PubMed ID: 2010244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [High frequency catheter ablation of left-sided manifest accessory conduction pathways during sinus rhythm and in continuous atrial fibrillation].
    Chen X; Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():121-5. PubMed ID: 7846941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Single-catheter approach to radiofrequency current ablation of accessory pathway in Wolff-Parkinson-White syndrome with recurrent rapid atrial fibrillation].
    Zhou S; Qi S; Shen X
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):369-70. PubMed ID: 12080651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supernormal conduction in the anomalous bundles of the Wolff-Parkinson-White syndrome: an overlooked electrophysiologic property with potential clinical implications.
    Chiale PA; Albino E; Garro HA; Selva H; Levi RJ; Sánchez RA; Elizari MV; Alvarez CB
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):181-91. PubMed ID: 17875945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome].
    Mabo P; Kermarrec A; Gras D; Paillard F; Bédossa M; Daubert C
    Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1443-8. PubMed ID: 1297293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency catheter ablation of accessory pathways during pre-excited atrial fibrillation: acute success rate and long-term clinical follow-up results as compared to those patients undergoing successful catheter ablation during sinus rhythm.
    Kose S; Amasyali B; Aytemir K; Can I; Kilic A; Kursaklioglu H; Iyisoy A; Isik E
    Heart Vessels; 2005 Jul; 20(4):142-6. PubMed ID: 16025362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of B-type natriuretic peptide levels on the suppression of accompanying atrial fibrillation in Wolff-Parkinson-White syndrome patients after accessory pathway ablation.
    Kawabata M; Goya M; Takagi T; Yamashita S; Iwai S; Suzuki M; Takamiya T; Nakamura T; Hayashi T; Yagishita A; Sasaki T; Takahashi Y; Ono Y; Hachiya H; Yamauchi Y; Otomo K; Nitta J; Okishige K; Nishizaki M; Iesaka Y; Isobe M; Hirao K
    J Cardiol; 2016 Dec; 68(6):485-491. PubMed ID: 26917195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between spontaneous atrial fibrillation and atrial vulnerability in patients with Wolff-Parkinson-White pattern.
    Gaita F; Giustetto C; Riccardi R; Mazza A; Mangiardi L; Rosettani E; Brusca A
    Pacing Clin Electrophysiol; 1990 Oct; 13(10):1249-53. PubMed ID: 1701539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
    Feld GK; Nademanee K; Stevenson W; Weiss J; Klitzner T; Singh BN
    Am Heart J; 1988 Jan; 115(1 Pt 1):102-7. PubMed ID: 3336964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The radiofrequency ablation of a left lateral accessory pathway during pre-excitation atrial fibrillation].
    Siller Rodríguez J; de la Fuente F; Cedillo Salazar F; Flores-Delgado I
    Arch Inst Cardiol Mex; 1998; 68(2):113-8. PubMed ID: 9810353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways.
    Haissaguerre M; Fischer B; Labbé T; Lemétayer P; Montserrat P; d'Ivernois C; Dartigues JF; Warin JF
    Am J Cardiol; 1992 Feb; 69(5):493-7. PubMed ID: 1736613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased P wave dispersion after the radiofrequency catheter ablation in overt pre-excitation patients: the role of atrial vulnerability.
    Soylu M; Demir AD; Ozdemir O; Soylu O; Topaloğlu S; Korkmaz S; Saşmaz A
    Int J Cardiol; 2004 Jun; 95(2-3):167-70. PubMed ID: 15193815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency catheter ablation of atrioventricular accessory pathways in Wolff-Parkinson-White syndrome with drug-refractory and symptomatic supraventricular tachycardia--its high effectiveness irrespective of accessory pathway location and properties.
    Iesaka Y; Takahashi A; Chun YH; Igawa M; Tokunaga T; Amemiya H; Fujiwara H; Aonuma K; Nogami A; Hiroe M
    Jpn Circ J; 1994 Oct; 58(10):767-77. PubMed ID: 7966998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological properties in paroxysmal atrial fibrillation complicated with the Wolff-Parkinson-White syndrome: comparison with paroxysmal atrial fibrillation alone.
    Gondo N; Kumagai K; Matsuo K; Annoura M; Moroe K; Arakawa K
    Cardiology; 1994; 84(4-5):292-7. PubMed ID: 8187115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atrial fibrillation in Wolff-Parkinson-White syndrome].
    Antunes E; Rasteiro R; Martins S; Oliveira M; Oliveira E; Menezes M; Cacela D; Soares RM; da Silva N; Gracias R; Antunes AM
    Rev Port Cardiol; 1999 Sep; 18(9):821-7. PubMed ID: 10536472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.